Savara (SVRA) Interest Expenses (2011 - 2026)
Savara's (SVRA) quarterly Interest Expenses came in at $617000.0 in Q1 2026, down 53.43% year-on-year from $1.3 million in Q1 2025, and up 126.04% on a QoQ basis from -$2.4 million in Q4 2025.
Savara (SVRA) Interest Expenses (2011 - 2026) Analysis & Trends
Savara (SVRA) has 16 years of Interest Expenses data on file, last reported at $617000.0 in Q1 2026.
- On a quarterly basis, Interest Expenses fell 53.43% year-over-year to $617000.0 in Q1 2026; TTM through Mar 2026 was $78000.0, a 97.31% decrease from a year earlier, with the FY2025 full-year figure at $142.7 million, up 32.95% from the prior year.
- Interest Expenses for Q1 2026 stood at $617000.0, up from -$2.4 million in the prior quarter.
- Over the last five years, Interest Expenses for SVRA reached as high as $1.3 million in Q1 2025 and fell as low as -$2.4 million in Q4 2025.
- Historically, Interest Expenses has averaged $312812.5 across 5 years, with a median of $474000.0 in 2022.
- Across the five-year window, Interest Expenses soared 411.11% in 2022 and slumped 569.11% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $428000.0 in 2022, then increased by 25.23% to $536000.0 in 2023, then decreased by 5.78% to $505000.0 in 2024, then slumped by 569.11% to -$2.4 million in 2025, then surged by 126.04% to $617000.0 in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $617000.0 in Q1 2026, -$2.4 million in Q4 2025, and $32000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 617,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 617,000.00 |
| Mar 31, 2026 | 617,000.00 |
| Dec 31, 2025 | -2.37 Mn |
| Dec 31, 2025 | -2.37 Mn |
| Jun 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 505,000.00 |
| Dec 31, 2024 | 505,000.00 |
| Sep 30, 2024 | 281,000.00 |
| Sep 30, 2024 | 281,000.00 |
| Jun 30, 2024 | 309,000.00 |
| Jun 30, 2024 | 309,000.00 |
| Mar 31, 2024 | 536,000.00 |
| Mar 31, 2024 | 536,000.00 |
| Dec 31, 2023 | 536,000.00 |
| Dec 31, 2023 | 536,000.00 |
| Sep 30, 2023 | 394,000.00 |
| Sep 30, 2023 | 394,000.00 |